ANDA 206760, held by Piramal Critical. Oxacillin Sodium.
As of Nov 15, 2026, ANDA 206760 (Oxacillin Sodium), held by Piramal Critical, was first approved by FDA on Oct 26, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxacillin SodiumEQ 10GM BASE/VIAL ยท injectable;injection | Oxacillin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
